Skip to content
Jennifer L. Richard, NP

Jennifer L. Richard, NP

Specialties

Neurology , Primary Care

No ratings currently available, see text in Ratings section below for explanation.

URochester Medical Faculty The University of Rochester Medical Faculty Group (URMFG) consists of over 900 specialist and primary care providers spanning 19 departments. URMFG is certified by the National Committee for Quality Assurance.
Accountable Health Partner Accountable Health Partners (AHP) is a network of over 2,000 community and UR medical faculty and a dozen leading hospitals throughout the region. AHP offers a full range of care.
Not Accepting New Patients

Contact

Locations

About Me

Education and Training
I am a Primary Care Nurse Practitioner and graduated from the University of Rochester Graduated Cum Laude as well as studied abroad at the University of Melbourne in Australia.

Philosophy
I believe that all patients deserve individualized and holistic care. I am p...
Education and Training
I am a Primary Care Nurse Practitioner and graduated from the University of Rochester Graduated Cum Laude as well as studied abroad at the University of Melbourne in Australia.

Philosophy
I believe that all patients deserve individualized and holistic care. I am passionate about both educating and empowering patients to be stewards of their own health as well as partnering with patients to develop treatment plans that are consistent with their values.

Special Interests
Geriatrics, Hematology/Oncology, and Neurology

On a Personal Note
I enjoy traveling and spending time with my family and pets.

Certified Specialties

Adult Gerontology Primary Care Nurse Practitioner - American Nurses Credentialing Center

Credentials

Education

MS | University of Rochester School of Nursing. 2014

Research

Currently assisting with coordination of POINT (Platelet-Oriented Inhibition in New TIA and minor ischemic stroke Trial and ZZ-3K3A-201 (NN104): A multi-center, Phase 2 study using a continual reassessment method to determine the safety and tolerability of 3K3A-APC, a recombinant variant of human ac...
Currently assisting with coordination of POINT (Platelet-Oriented Inhibition in New TIA and minor ischemic stroke Trial and ZZ-3K3A-201 (NN104): A multi-center, Phase 2 study using a continual reassessment method to determine the safety and tolerability of 3K3A-APC, a recombinant variant of human activated protein C, in combination with tissue plasminogen activator (tPA), mechanical thrombectomy, or both in moderate to severe acute ischemic stroke research trials.

Use of the MOCA for Patients Presenting to a Memory Disorder's Clinic
Author(s): Lisa Boyle, Jen Richard
Type: Other
Publisher: Poster
,Date Published: 1/1/2009

Donepezil in the treatment of severe Alzheimer's disease
Author(s): Jennifer Richard, Kelly Cosman, Anton Porsteinsson
Type: Journal
Publisher: Aging Health
Date Published: 8/1/2007

Publications

Journal Articles

Donepezil in the treatment of severe Alzheimer's disease

Aging Health. 2007; .

Ratings & Comments

At University of Rochester Medicine, we believe that patients should be empowered to make the right decisions regarding their personal healthcare. To do so, transparency is critical. URochester Medicine partners with Press Ganey, to survey our patients about all aspects of their care experience. We are now putting this pertinent information at your fingertips by displaying star ratings for our providers along with anonymous patient comments on our website. This will help you make better-informed choices about how and with whom you seek care. Click here to learn more about the surveys used to generate this vital information. Learn more about our survey process.